SCOPUS 정보 검색 플랫폼

Cancer Research

Volumn 61, Issue 16, 2001, Pages 6145-6150

Nontoxic doses of suramin enhance activity of paclitaxel against lung metastases

(4) Song, S a Wientjes, M G a Walsh, C a Au, J L S a

a OHIO STATE UNIVERSITY (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; SURAMIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; DRUG EFFECT; HUMAN; HUMAN CELL; LUNG METASTASIS; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PACLITAXEL; PROSTATIC NEOPLASMS; RATS; SURAMIN; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035881312 PISSN: 00085472 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (57)

References (53)

1
- 0000289388
- Principles of molecular cell biology of cancer: Cancer metastasis
- V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.). Philadelphia: J. B. Lippincott Co.
- (1993) Principles & Practice of Oncology, Ed. 4 , pp. 134-149
- Liotta, L.A.¹ Stetler-Stevenson, W.G.²

2
- 0002516625
- Principles of cancer biology: Biology of cancer metastasis
- V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.). Philadelphia: J. B. Lippincott Co.
- (1990) Principles & Practice of Oncology , pp. 80-92
- Fidler, I.J.¹ Hart, I.R.²

3
- 0028245129
- Modulation of tumor cell response to chemotherapy by the organ environment
- (1994) Cancer Metastasis Rev. , vol.13 , pp. 209-222
- Fidler, I.J.¹ Wilmanns, C.² Staroselsky, A.³ Radinsky, R.⁴ Dong, Z.⁵ Fan, D.⁶

4
- 0028342711
- Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells
- (1994) J. Natl. Cancer Inst. (Bethesda) , vol.76 , pp. 913-920
- Dong, Z.¹ Radinsky, R.² Fan, D.³ Tsan, R.⁴ Bucana, C.D.⁵ Wilmanns, C.⁶ Fidler, I.J.⁷

5
- 0030001001
- Clinical trials of p-glycoprotein reversal in solid tumors
- (1996) Eur. J. Cancer , vol.32 , pp. 1070-1081
- Ferry, D.R.¹ Traunecker, H.² Kerr, D.J.³

6
- 0029999404
- How to probe clinical tumour samples for p-glycoprotein and multidrug resistance-associated protein
- (1996) Eur. J. Cancer , vol.32 , pp. 1024-1033
- Broxterman, H.J.¹ Lankelma, J.² Pinedo, H.M.³

7
- 0029952894
- Differential effect of Taxol in rat primary and metastatic prostate tumors: Site-dependent pharmacodynamics
- (1996) Pharm. Res. , vol.13 , pp. 1305-1312
- Yen, W.-C.¹ Wientjes, M.G.² Au, J.L.-S.³

8
- 12944272151
- Fibroblast growth factors: An epigenetic mechanism of broad spectrum resistance to anticancer drugs
- (2000) Proc. Natl. Acad. Sci. USA , vol.97 , pp. 8658-8663
- Song, S.¹ Wientjes, M.G.² Gan, Y.³ Au, J.L.-S.⁴

9
- 0034020722
- Chemotherapy in non-small cell lung cancer
- (2000) Investig. New Drugs , vol.18 , pp. 157-186
- Sweeney, C.J.¹ Sandler, A.B.²

10
- 0033837509
- Second-line chemotherapy for recurrent non-small cell lung cancer: Do new agents make a difference?
- (2000) Lung Cancer , vol.29 , pp. 91-104
- Ferrigno, D.¹ Buccheri, G.²

11
- 0021941832
- Factors influencing phenotypic diversity of human prostate carcinoma cells metastasizing in athymic nude mice
- (1985) Exp. Cell Biol. , vol.53 , pp. 163-169
- Ware, J.L.¹ Lieberman, A.P.² Webb, K.S.³ Vollmer, R.T.⁴

12
- 14444280360
- Pharmacodynamics of immediate and delayed effects of paclitaxel: Role of slow apoptosis and intracellular drug retention
- (1998) Cancer Res. , vol.58 , pp. 2141-2148
- Au, J.L.¹ Li, D.² Gan, Y.³ Gao, X.⁴ Johnson, A.L.⁵ Johnston, J.⁶ Millenbaugh, N.J.⁷ Jang, S.H.⁸ Kuh, H.-J.⁹ Chen, C.-T.¹⁰ Wientjes, M.G.¹¹

13
- 0021118703
- Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
- (1984) Adv. Enzyme Regul. , vol.22 , pp. 27-55
- Chou, T.-C.¹ Talalay, P.²

14
- 0029877212
- Pharmacodynamics of Taxol in human head and neck tumors
- (1996) Cancer Res. , vol.56 , pp. 2086-2093
- Gan, Y.¹ Wientjes, M.G.² Schuller, D.E.³ Au, J.L.-S.⁴

15
- 0028136653
- Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques
- (1994) Lab. Investig. , vol.71 , pp. 219-225
- Gold, R.¹ Schmied, M.² Giegerich, G.³ Breitschopf, H.⁴ Hatung, H.P.⁵ Toyka, K.V.⁶ Lassmann, H.⁷

16
- 0031888788
- Effectiveness of cisplatin, paclitaxel, and suramin against human malignant mesothelioma xenografts in athymic nude mice
- (1998) J. Surg. Oncol. , vol.67 , pp. 104-111
- Chahinian, A.P.¹ Mandeli, J.P.² Gluck, H.³ Naim, H.⁴ Teirstein, A.S.⁵ Holland, J.F.⁶

17
- 0030834211
- Effect of suramin on human esophageal cancer cells in vitro and in vivo
- (1997) Scand. J. Gastroenterol. , vol.32 , pp. 824-828
- Shin, R.¹ Naomoto, Y.² Kamikawa, Y.³ Tanaka, N.⁴ Orita, K.⁵

18
- 0030696331
- Induction of Mdm2 and enhancement of cell survival by bFGF
- (1997) Oncogene , vol.15 , pp. 2717-2725
- Shaulian, E.¹ Resnitzky, D.² Shifman, O.³ Blandino, G.⁴ Amsterdam, A.⁵ Yayon, A.⁶ Oren, M.⁷

19
- 0031045135
- Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis
- (1997) Leukemia (Baltimore) , vol.11 , pp. 258-265
- Konig, A.¹ Menzel, T.² Lynen, S.³ Wrazel, L.⁴ Rosen, A.⁵ Al-Katib, A.⁶ Raveche, E.⁷ Gabrilove, J.L.⁸

20
- 0030989030
- 2 delay and a hyperphosphorylation of p34CDC2 in HeLa cells
- (1997) Cancer Res. , vol.57 , pp. 1364-1370
- Cohen-Jonathan, E.¹ Toulas, C.² Nonteil, S.³ Couderc, B.⁴ Maret, A.⁵ Bard, J.J.⁶ Prats, H.⁷ Daly-Schveitzer, N.⁸ Favre, G.⁹

21
- 0032579442
- Expression of basic fibroblast growth factor is associated with resistance to cisplatin in a human bladder cancer cell line
- (1998) Cancer Lett. , vol.123 , pp. 121-126
- Miyake, H.¹ Hara, I.² Gohji, K.³ Yoshimura, K.⁴ Arakawa, S.⁵ Kamidono, S.⁶

22
- 0028044741
- Fibroblast growth factor mediated alterations in drug resistance, and evidence of gene amplification
- (1994) Oncogene , vol.9 , pp. 491-499
- Huang, A.¹ Wright, J.A.²

23
- 0027997191
- Aberrant expression of basic fibroblast growth factor in NIH-3T3 cells alters drug resistance and gene amplification potential
- (1994) Exp. Cell Res. , vol.213 , pp. 335-339
- Huang, A.¹ Jin, H.² Wright, J.A.³

24
- 0031935621
- Insulin-like growth factor-1 promotes multidrug resistance in MCLM colon cancer cells
- (1998) J. Cell. Physiol. , vol.175 , pp. 141-148
- Guo, Y.-S.¹ Jin, G.-F.² Houston, C.W.³ Thompson, J.C.⁴ Townsend, C.M.⁵

25
- 0028227416
- Epidermal growth factor and insulin-like growth factor-1 protect MDA-231 cells from death induced by actinomycin D: The involvement of growth factors in drug resistance. In Vitro Cell
- (1994) Dev. Biol. Anim. , vol.30 A , pp. 336-343
- Geier, A.¹ Hemi, R.² Haimsohn, M.³ Berry, R.⁴ Malik, Z.⁵ Karasik, A.⁶

26
- 0004255522
- FGF expression correlates with paclitaxel resistance in human tumors
- (2000) Proc. Am. Assoc. Cancer Res. , vol.41 , pp. 843
- Gan, Y.¹ Lu, J.² Wientjes, M.G.³ Au, J.L.-S.⁴

27
- 0022370712
- Suramin binds to platelet-derived growth factor and inhibits its biological activity
- (1985) J. Cell. Biochem. , vol.29 , pp. 265-273
- Hosang, M.¹

28
- 0342814999
- Blockade of autocrine stimulation in simian sarcoma virus-transformed cells reverses down-regulation of platelet-derived growth factor receptors
- (1984) Proc. Natl. Acad. Sci. USA , vol.81 , pp. 7466-7470
- Garrett, J.S.¹ Coughlin, S.R.² Niman, H.L.³ Tremble, P.M.⁴ Giels, G.M.⁵ Williams, L.T.⁶

29
- 0342350445
- Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin
- (1986) Proc. Natl. Acad. Sci. USA , vol.83 , pp. 6440-6444
- Betsholtz, C.¹ Johnsson, A.² Heldin, C.-H.³ Westermark, B.⁴

30
- 0023245094
- Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells
- (1987) J. Cell. Physiol. , vol.132 , pp. 143-148
- Coffey R.J., Jr.¹ Leof, E.B.² Shipley, G.D.³ Moses, H.L.⁴

31
- 0002496118
- Suramin interferes with the binding of insulin-like growth factor 1 (IGF-I) to human osteosarcoma cells and blocks IGF-I stimulated proliferation
- (1990) Proc. Am. Soc. Clin. Oncol. , vol.9 , pp. 54
- Pollak, M.¹ Richard, M.²

32
- 0034128221
- Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: Results of a randomized Phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone
- (2000) J. Clin. Oncol. , vol.18 , pp. 1440-1450
- Small, E.J.¹ Meyer, M.² Marshall, M.E.³ Reyno, L.M.⁴ Meyers, F.J.⁵ Natale, R.B.⁶ Lenehan, P.F.⁷ Chen, L.⁸ Slichenmyer, W.J.⁹ Eisenberger, M.¹⁰

33
- 0004315407
- Activity of suramin (Su) in prostate cancer (PC) observed in a Phase I trial
- (1992) Proc. Am. Soc. Clin. Oncol. , vol.11 , pp. 201
- Tkaczuk, K.¹ Eisenberger, M.² Sinibaldi, V.³ Reyno, L.⁴ Jodrell, D.⁵ Jacobs, S.⁶ Melink, T.⁷ Pearl, P.⁸ Aisner, J.⁹ Van Echo, D.¹⁰ Egorin, M.¹¹

34
- 0004255524
- Phase I-II suramin (SRM) study in advanced cancer patients
- (1991) Proc. Am. Assoc. Cancer Res. , vol.32 , pp. 175
- Armand, J.P.¹ Bonnay, M.² Gandia, D.³ Cvitkovic, E.⁴ De Braud, F.⁵ Bertheault, F.⁶ Droz, J.P.⁷ Carde, P.⁸ Schlumberger, M.⁹ Fourcault, D.¹⁰

35
- 0001549783
- Suramin in hormone-resistant metastatic prostatic cancer: Significant anticancer activity but unanticipated toxicity
- (1991) Proc. Am. Soc. Clin. Oncol. , vol.10 , pp. 178
- Ahmannn, F.R.¹ Schwartz, J.² Dorr, R.³ Salmon, S.⁴

36
- 0029112847
- Development and validation of a pharmacokinetically based fixed dosing scheme for suramin
- (1995) J. Clin. Oncol. , vol.13 , pp. 2187-2195
- Reyno, L.M.¹ Egorin, M.J.² Eisenberger, M.A.³ Sinibaldi, V.J.⁴ Zuhowski, E.G.⁵ Sridhara, R.⁶

37
- 0025354734
- Suramin-induced polyneuropathy
- (1990) Neurology , vol.40 , pp. 954-960
- La Rocca, R.V.¹ Meet, J.² Gilliatt, R.W.³ Stein, C.A.⁴ Cassidy, J.⁵ Myers, C.E.⁶ Dalakas, M.C.⁷

38
- 0028068481
- Acute renal toxicity associated with suramin in the treatment of prostate cancer
- (1994) Cancer (Phila.) , vol.74 , pp. 1612-1614
- Figg, W.D.¹ Cooper, M.R.² Thibault, A.³ Headlee, D.⁴ Humphrey, J.⁵ Bergan, R.C.⁶ Reed, E.⁷ Sartor, O.⁸

39
- 0022642208
- Suramin and function of the adrenal cortex
- (1986) Ann. Intern. Med. , vol.104 , pp. 286-287
- Stein, C.A.¹ Saville, W.² Yarchoan, R.³ Broder, S.⁴ Gelmann, E.P.⁵

40
- 0027516709
- Immune-mediated thrombocytopenia secondary to suramin
- (1993) Cancer (Phila.) , vol.71 , pp. 851-854
- Seidman, A.D.¹ Schwartz, M.² Reich, L.³ Scher, H.I.⁴

41
- 0023864383
- Circulating glycosaminoglycan anticoagulants associated with suramin treatment
- (1988) Blood , vol.71 , pp. 273-279
- Horne III, M.K.¹ Stein, C.A.² LaRocca, R.V.³ Myers, C.E.⁴

42
- 0029120380
- Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suramin
- (1995) J. Clin. Oncol. , vol.13 , pp. 2223-2229
- Bitton, R.J.¹ Figg, W.D.² Venzon, D.J.³ Dalakas, M.C.⁴ Bowden, C.⁵ Headlee, D.⁶ Reed, E.⁷ Myers, C.E.⁸ Cooper, M.R.⁹

43
- 0029806192
- Mineralocorticoid insufficiency due to suramin therapy
- (1996) Cancer (Phila.) , vol.78 , pp. 2411-2420
- Kobayashi, K.¹ Weiss, R.E.² Vogelzang, N.J.³ Vokes, E.E.⁴ Janisch, L.⁵ Ratain, M.J.⁶

44
- 0029094568
- Cutaneous eruptions from suramin. A clinical and histopathologic study of 60 patients
- (1995) Arch. Dermatol. , vol.131 , pp. 1147-1153
- Lowitt, M.H.¹ Eisenberger, M.² Sina, B.³ Kao, G.F.⁴

45
- 0003391197
- Suramin sodium
- R. Dorr and D. Von Hoff (eds.). Norwalk, CT: Appleton & Lange
- (1994) Cancer Chemotherapy Handbook, Ed. 2 , pp. 859-866

46
- 0027132214
- Development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer
- (1994) J. Clin. Oncol. , vol.12 , pp. 166-175
- Jodrell, D.I.¹ Reyno, L.M.² Srihara, R.³ Eisenberger, M.A.⁴ Tkaczuk, K.H.⁵ Zuhowski, E.G.⁶ Sinibaldi, V.J.⁷ Novak, M.J.⁸ Suramin, E.M.J.⁹

47
- 0031896857
- Phase I study of suramin combined with doxorubicin in the treatment of androgen-independent prostate cancer
- (1998) Clin. Cancer Res. , vol.4 , pp. 1193-1201
- Tu, S.¹ Pagliaro, L.C.² Banks, M.E.³ Amato, R.J.⁴ Millikan, R.E.⁵ Bugazia, N.A.⁶ Madden, T.⁷ Newman, R.A.⁸ Logothetis, C.J.⁹

48
- 0032467507
- Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+ LV-based chemotherapy
- (1998) Tumori , vol.84 , pp. 666-668
- Falcone, A.¹ Pfanner, E.² Brunetti, I.³ Allegrini, G.⁴ Lencioni, M.⁵ Galli, C.⁶ Masi, G.⁷ Danesi, R.⁸ Antonuzzo, A.⁹ Del Tacca, M.¹⁰ Conte, P.F.¹¹

49
- 0033178459
- Suramin in combination with weekly epirubicin for patients with advanced hormone-refractory prostate carcinoma
- (1999) Cancer (Phila.) , vol.86 , pp. 470-476
- Falcone, A.¹ Antonuzzo, A.² Danesi, R.³ Allegrini, G.⁴ Monica, L.⁵ Pfanner, E.⁶ Masi, G.⁷ Ricci, S.⁸ Del Tacca, M.⁹ Conte, P.¹⁰

50
- 0027267645
- Suramin in combination with mitomycin C in hormone-resistant prostate cancer. A Phase II clinical study
- (1993) Ann. Oncol. , vol.4 , pp. 567-573
- Rapoport, B.L.¹ Falkson, G.² Raats, J.I.³ De Wet, M.⁴ Lotz, B.P.⁵ Potgieter, H.C.⁶

51
- 0028364285
- Effects of suramin on expression of proliferation associated nuclear antigens in DU-145 prostate carcinoma cells
- (1994) Biochem. Biophys. Res. Commun. , vol.201 , pp. 581-588
- Qiao, L.¹ Pizzolo, J.² Melamed, M.³

52
- 0029991322
- 1 checkpoint
- (1996) Clin. Cancer Res. , vol.2 , pp. 269-276
- Howard, S.P.¹ Park, S.J.² Hughes-Davies, L.³ Coleman, C.N.⁴ Price, B.D.⁵

53
- 0030807492
- Apoptosis and clonogenic cell death in PC3 human prostate cancer cells after treatment with γ radiation and suramin
- (1997) Radiat. Res. , vol.148 , pp. 105-114
- Palayoor, S.T.¹ Bump, E.A.² Teicher, B.A.³ Coleman, C.N.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.